Member Info for 13thmonkey

Given that he's just listed a company I do wonder how he'll react in six months time to people drawing random lines on a chart and suggesting that these mean it'll go down.

Those resistance lines really do look like random lines on a page

MCB, it's just eventually for me, it's not a prediction it's my target, >10bn Mcap or offer. With a 5x peak revenue valuation needing just 2bn, the question to me is can this be forseen by the buyer, and I think it can.

I'm a small investor, the numbers in waiting for are not mentionable as they'd be too rampy but I think are perfectly achievable, can't see why a multiple of £2-3bn peak revenue for the actual plus potential suite of precision drugs can't get there. I'm after F-you money, not just a nice profit, and I think this can do it, but I'm managing risk by this being a healthy fraction of the pf, so I'm not likely to hold IMO.

And if there are other enzymes providing they are at low enough levels it's not an issue, most will be cleaved in the tumour. The body can cope with doxy if released slowly enough is my understanding.

Get a better broker, should be instant, they know the money's available.

Do you understand that ANIC just invests in other companies, it doesn't make this stuff?

Weren't we being told by some gfwit that there was no membrane?

Apparently it's happened before.

It's literally above the question on the header section where it states the open price. 97p officially. MMs will do their thing though.

Balloons to avoid blood flow to the heart will create problems...

Bella, I'd be very very happy if they rocked up next week talking about even a few million units of sales, but until someone official states that all the Chinese tat is pointless then we're not able to compete on quality as people will buy the cheapest assuming they are all good enough. So it's a lost cause until the others are taken off the market unless we are willing to accept such a low margin as to make it pointless. Now waiting for the real show to start.

If no-one in officialdom is going to say they are ****e, then to my mind we'd never be able to compete and abandoning it would be best thing to do, the indications that we were given was that Avacta did not think it's performance was good enough rather than any official body (not that they actually looked at ours anyway). Concept is proven for the potential for a wide range of rapid tests for in-appointment diagnosis, just need the targets of interest now.

Steve? that bar steward! that rhymes with eve?

It's going up because people are buying and no-one is selling at lower prices, nothing to RNS. It might be a pre meeting rise to fall back again, it might not.

As someone else days yesterday, there are hundreds of trials at any one time...

Wah wah wah, I over invested so I'm going make subtle digs at the company.

migsmcl186, that a 3bn valuation, is that really impossible?

There are sharper tools

And? that's just an algorithmic analysis of holders, the mechanism that created it might know what sector it's in, and have some idea of if those values are normal or abnormal for the sector but that's all. No human will have touched those words.